JP2017507670A5 - - Google Patents

Download PDF

Info

Publication number
JP2017507670A5
JP2017507670A5 JP2016570934A JP2016570934A JP2017507670A5 JP 2017507670 A5 JP2017507670 A5 JP 2017507670A5 JP 2016570934 A JP2016570934 A JP 2016570934A JP 2016570934 A JP2016570934 A JP 2016570934A JP 2017507670 A5 JP2017507670 A5 JP 2017507670A5
Authority
JP
Japan
Prior art keywords
pgf2
composition
pacap
derivatives
sdf
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2016570934A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017507670A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2015/017392 external-priority patent/WO2015127474A1/en
Publication of JP2017507670A publication Critical patent/JP2017507670A/ja
Publication of JP2017507670A5 publication Critical patent/JP2017507670A5/ja
Pending legal-status Critical Current

Links

JP2016570934A 2014-02-24 2015-02-24 ヒト褐色脂肪細胞前駆体の分化を誘導するための方法および組成物 Pending JP2017507670A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201461966496P 2014-02-24 2014-02-24
US61/966,496 2014-02-24
PCT/US2015/017392 WO2015127474A1 (en) 2014-02-24 2015-02-24 Methods and compositions for inducing differentiation of human brown adipocyte progenitors

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2019110252A Division JP2019193639A (ja) 2014-02-24 2019-06-13 ヒト褐色脂肪細胞前駆体の分化を誘導するための方法および組成物

Publications (2)

Publication Number Publication Date
JP2017507670A JP2017507670A (ja) 2017-03-23
JP2017507670A5 true JP2017507670A5 (enExample) 2018-03-22

Family

ID=53879173

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2016570934A Pending JP2017507670A (ja) 2014-02-24 2015-02-24 ヒト褐色脂肪細胞前駆体の分化を誘導するための方法および組成物
JP2019110252A Pending JP2019193639A (ja) 2014-02-24 2019-06-13 ヒト褐色脂肪細胞前駆体の分化を誘導するための方法および組成物
JP2020206597A Active JP7256165B2 (ja) 2014-02-24 2020-12-14 ヒト褐色脂肪細胞前駆体の分化を誘導するための方法および組成物
JP2023056276A Pending JP2023073455A (ja) 2014-02-24 2023-03-30 ヒト褐色脂肪細胞前駆体の分化を誘導するための方法および組成物

Family Applications After (3)

Application Number Title Priority Date Filing Date
JP2019110252A Pending JP2019193639A (ja) 2014-02-24 2019-06-13 ヒト褐色脂肪細胞前駆体の分化を誘導するための方法および組成物
JP2020206597A Active JP7256165B2 (ja) 2014-02-24 2020-12-14 ヒト褐色脂肪細胞前駆体の分化を誘導するための方法および組成物
JP2023056276A Pending JP2023073455A (ja) 2014-02-24 2023-03-30 ヒト褐色脂肪細胞前駆体の分化を誘導するための方法および組成物

Country Status (5)

Country Link
US (2) US20220331403A1 (enExample)
EP (2) EP3110946B1 (enExample)
JP (4) JP2017507670A (enExample)
CN (1) CN106255748B (enExample)
WO (1) WO2015127474A1 (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101452518B1 (ko) 2005-08-22 2014-10-21 멜리어 파마슈티칼스 아이, 인코포레이티드 Ｌｙｎ 키나제 활성의 조절 및 관련된 장애의 치료를 위한방법 및 제제
WO2011150300A1 (en) 2010-05-28 2011-12-01 Melior Pharmaceuticals I, Inc. Prevention of pancreatic beta cell degeneration
WO2017172881A1 (en) * 2016-03-29 2017-10-05 Ohio State Innovation Foundation Thermogenic compositions and methods
JP6909569B2 (ja) * 2016-09-16 2021-07-28 オリザ油化株式会社 肌質改善剤
ES3055314T3 (en) 2017-01-06 2026-02-11 Iovance Biotherapeutics Inc Expansion of tumor infiltrating lymphocytes with potassium channel agonists and therapeutic uses thereof
CN108619490A (zh) * 2017-03-22 2018-10-09 天士力医药集团股份有限公司 一种长效化突变的人源成纤维生长因子的新用途
EP3609500B1 (en) 2017-04-10 2024-11-13 Melior Pharmaceuticals I, Inc. Treatment of adipocytes
CN109893655B (zh) * 2017-12-11 2021-07-20 义慧科技(深圳)有限公司 miR-327抑制剂和/或FGF10促进剂在预防和/或治疗糖尿病的药物中的应用
CN109893656B (zh) * 2017-12-11 2021-07-20 义慧科技(深圳)有限公司 miR-327抑制剂和/或FGF10促进剂在预防和/或治疗脂肪代谢症药物中的应用
JP2020143008A (ja) * 2019-03-05 2020-09-10 達也 楠堂 新規褐色脂肪細胞分化誘導剤
CN109820857A (zh) * 2019-03-27 2019-05-31 中国科学院广州生物医药与健康研究院 化合物dk45的新应用
CN110747163B (zh) * 2019-11-13 2021-06-11 暨南大学 一种提高人脂肪间充质干细胞成脂分化的方法及其专用培养基
KR102150821B1 (ko) * 2020-01-22 2020-09-03 주식회사 에이스바이오메드 간 질환 치료용 또는 치료 효과 증진을 위한 콜히친 복합제제
EP4149962A4 (en) * 2020-05-11 2024-06-19 Energesis Pharmaceuticals, Inc. Methods and compositions for inducing brown adipogenesis
KR102346790B1 (ko) * 2021-04-29 2022-01-04 주식회사 에이스바이오메드 콜히친과 메트포르민을 유효성분으로 하는 항비만 치료제
CN114225006B (zh) * 2021-12-22 2023-10-13 南京市妇幼保健院 一种棕色脂肪细胞分泌肽在低体温疾病防治中的应用
CN115554285B (zh) * 2022-09-25 2026-03-17 华北理工大学 3-去甲基秋水仙碱在药物中的应用

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH10330284A (ja) * 1997-05-30 1998-12-15 Sumitomo Pharmaceut Co Ltd 肝細胞保護剤
JPH10330285A (ja) * 1997-05-30 1998-12-15 Sumitomo Pharmaceut Co Ltd 血糖降下剤
US20050026832A1 (en) * 1997-11-25 2005-02-03 Genentech, Inc. Fibroblast growth factor-19 (FGF-19) nucleic acids and polypeptides and methods of use for the treatment of obesity and related disorders
US6242563B1 (en) * 1998-07-20 2001-06-05 Societe De Conseils De Recherches Et D'applications Scientifiques, Sas Peptide analogues
US20050009739A1 (en) * 2002-02-14 2005-01-13 Wei Wang Formulation strategies in stabilizing peptides in organic solvents and in dried states
JP2007523840A (ja) * 2003-04-30 2007-08-23 ワラタ ファーマシューティカルズ， インコーポレイテッド ケラチノサイト増殖因子アゴニストおよびカストリン化合物を組み合わせた使用
DK1677735T3 (da) * 2003-10-17 2014-10-27 Joslin Diabetes Center Inc Fremgangsmåder og sammensætninger til modulering af adipocytfunktion
WO2006108023A2 (en) * 2005-04-04 2006-10-12 Joslin Diabetes Center, Inc. Methods and compositions for modulating necdin function
US20100150885A1 (en) * 2005-06-01 2010-06-17 Joslin Diabetes Center, Inc. Methods and compositions for inducing brown adipogenesis
WO2009137613A2 (en) * 2008-05-06 2009-11-12 Joslin Diabetes Center, Inc. Methods and compositions for inducing brown adipogenesis
US8455204B2 (en) * 2008-05-27 2013-06-04 Energesis Pharmaceuticals, Inc. Brown adipocyte progenitors in human skeletal muscle and methods for identifying differentiation agents therefor
FR2932818B1 (fr) * 2008-06-23 2015-12-04 Centre Nat Rech Scient Lignee d'adipocytes bruns humains et procede de differenciation a partir d'une lignee de cellules hmads.
US20110130385A1 (en) * 2008-07-23 2011-06-02 De Lera Ruiz Manuel Bicyclic Heterocylic Derivatives and Methods of Use
JP5393119B2 (ja) * 2008-12-05 2014-01-22 日本メナード化粧品株式会社 幹細胞の褐色脂肪細胞への分化誘導方法
EP2412800A1 (en) * 2010-07-29 2012-02-01 Koninklijke Nederlandse Akademie van Wetenschappen Liver organoid, uses thereof and culture method for obtaining them
CN102316892B (zh) * 2009-02-12 2014-06-04 西马生物医学计划公司 心肌营养素-1用于治疗代谢病的用途
JP5908406B2 (ja) * 2009-11-02 2016-04-26 ジ アドミニストレーターズ オブ ザ トゥレーン エデュケーショナル ファンド 下垂体アデニル酸シクラーゼ活性化ポリペプチド（ｐａｃａｐ）の類似体およびその使用方法
WO2011126790A1 (en) 2010-03-29 2011-10-13 Joslin Diabetes Center, Inc. Methods and compositions for inducing brown adipogenesis
US20120190615A1 (en) * 2011-01-20 2012-07-26 Sanford-Burnham Medical Research Institute Methods and compositions for inducing weight loss
US9492485B2 (en) * 2011-04-27 2016-11-15 Id Pharma Co., Ltd. Pluripotent stem cell-derived brown adipocytes, pluripotent stem cell-derived cell aggregate, method for producing same, and cell therapy and medical therapy therefor
WO2012156968A2 (en) * 2011-05-19 2012-11-22 Ariel - University Research And Development Company, Ltd. Use of mesenchymal stem cells for the improvement of affective and cognitive function
HK1202309A1 (en) * 2011-11-10 2015-09-25 释放能量医药股份有限公司 Brown adipocyte progenitors in human skeletal muscle
SG10201607521PA (en) * 2012-03-12 2016-10-28 Univ Singapore Generation of brown adipose tissue (bat) from mesenchymal cells
CA2917674A1 (en) * 2012-08-10 2014-02-13 The Trustees Of Columbia University In The City Of New York Injectable brown adipose microtissues for treatment and prevention of obesity and diabetes
WO2014156462A1 (ja) * 2013-03-29 2014-10-02 ユーハ味覚糖株式会社 白色脂肪細胞の褐色様脂肪細胞分化誘導剤

Similar Documents

Publication Publication Date Title
JP7256165B2 (ja) ヒト褐色脂肪細胞前駆体の分化を誘導するための方法および組成物
Quijada et al. The role of the epicardium during heart development and repair
Dore-Duffy Pericytes: pluripotent cells of the blood brain barrier
Won et al. Cell surface engineering to enhance mesenchymal stem cell migration toward an SDF-1 gradient
KR102066987B1 (ko) 폴리펩티드
KR101694405B1 (ko) 폴리펩티드―중합체 접합체 및 그의 사용 방법
US20210393699A1 (en) Factors and cells that provide for induction of bone, bone marrow, and cartilage
JP7617603B2 (ja) Ｒ－スポンジン（ｒｓｐｏ）サロゲート分子
RU2019112897A (ru) Комбинаторная терапия с агонистами cnp контролируемого высвобождения
KR20160079776A (ko) 변형된 치료제 및 이의 조성물
CA2976376A1 (en) Nucleic acid products and methods of administration thereof
US20190300851A1 (en) Human stem cell derived endothelial cells, endothelial-hepatocyte co-culture system and uses thereof
Lin et al. Multidomain synthetic peptide B2A2 synergistically enhances BMP‐2 in vitro
JP2008546707A (ja) 創傷治癒
Liu et al. The influence of inflammatory cytokines on the proliferation and osteoblastic differentiation of MSCs
Kim et al. An approach for half-life extension and activity preservation of an anti-diabetic peptide drug based on genetic fusion with an albumin-binding aptide
Shao et al. The cardiac repair benefits of inflammation do not persist: evidence from mast cell implantation
CA2995749A1 (en) Compounds for inducing tissue formation and uses thereof
JP6235639B2 (ja) Ｅｐｈ型マ−カ−の細胞／リガンド標識システム、そのシステムからなる細胞物質ならびにその製造方法および前脈管形成としての用途
N. Dube et al. Thymosin β4 protein therapy for cardiac repair
Edwards et al. Biochemically engineered stromal cell-derived factor 1-alpha analog increases perfusion in the ischemic hind limb
CA3235565A1 (en) Truncated and fusion proteins
US20160024249A1 (en) Temperature-Responsive Polymer Compositions and Methods of Use
WO2019151098A1 (ja) インスリン産生細胞の製造方法
Chan et al. Harnessing endogenous intra-and extra-cardiac stem cells for cardiac regeneration–hope or hype?